Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis
Clinical trial NCT03686969 · TERMINATED
Trial details
- NCT number
- NCT03686969
- Sponsor
- Octapharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-02
- Primary completion
- 2018-11-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.